Vinati Organics Limited (NSE: VINATIORGA | BSE: 524200)
Source: Vinati Organics Limited Annual Report FY 2025-26 (Fiscal Year Ended March 31, 2026)
📋 Quick Facts: Company Snapshot
| Attribute | Disclosed Detail |
|---|---|
| Official Company Name | Vinati Organics Limited |
| Corporate Identity Number (CIN) | L24116MH1989PLC052224 |
| ISIN | INE410B01037 |
| Stock Exchange Listing | NSE: VINATIORGA | BSE: 524200 |
| Date of Incorporation / Founding Year | June 15, 1989 |
| Founders / Key Founding Figures | Mr. Vinod Saraf (Founder & Executive Chairman) |
| Registered Office | B-12 & B-13/1, MIDC Industrial Area, Mahad – 402 309, District Raigad, Maharashtra, India |
| Corporate Headquarters | Parinee Crescenzo, 1102, 11th Floor, ‘A’ Wing, ‘G’ Block, Plot No. C38 & C39, Behind MCA, Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051, Maharashtra, India |
| Telephone & Official IR Email | Tel: +91-22-61240444 / 428 | Email: shares@vinatiorganics.com |
| Chairman | Mr. Vinod Saraf (Executive Chairman) |
| Managing Director & CEO | Ms. Vinati Saraf Mutreja |
| Chief Financial Officer (CFO) | Mr. Gulshan Kumar Sakhuja (w.e.f. November 06, 2025) |
| Company Secretary & Compliance Officer | Mr. Milind A. Wagh |
| Promoter & Holding Structure | Promoter & Promoter Group led by Vinod Saraf, Suchir Chemicals Pvt. Ltd., Vinod Saraf Family Trust, and Kavita Vinod Saraf Family Trust |
| Industry / Sector Classification | Specialty Chemicals / Organic Intermediates (NIC Code: 20119 – Manufacturing of organic and inorganic chemical compounds) |
| Total Employees / Workforce Split | Permanent Employees: 1,362 | Contractual Workers: 678 | Other than Permanent Employees: 69 | Total Workforce: 2,109 |
| Manufacturing Plants Count | 4 state-of-the-art manufacturing sites across 2 operational complexes (3 sites in Mahad, Maharashtra including Veeral Organics complex; 1 site in Lote, Maharashtra) |
| Credit Ratings & Rating Agency | CARE AA+; Stable / CARE A1+ (Reaffirmed by CARE Ratings Ltd. for ₹237.00 Crores bank facilities) |
| Statutory Auditors | M. M. Nissim & Co. LLP, Chartered Accountants (Firm Regn. No. 107122W/W100672) |
| Secretarial Auditors | VKM & Associates, Practising Company Secretaries |
| Cost Auditors | M/s. N. Ritesh & Associates, Cost Accountants (FRN: R10065) |
| Registrar and Share Transfer Agent (RTA) | MUFG Intime India Private Limited, C-101, Embassy 247, LBS Marg, Vikhroli (West), Mumbai – 400 083 |
🏢 The Corporate Identity: Vinati Organics Overview, Promoters & History
The Big Picture: Business Model & Core Value Proposition
Vinati Organics Limited (VOL) is a globally integrated specialty chemicals manufacturer operating at the intersection of process innovation, synthetic chemistry engineering, and deep backward integration. Established over three decades ago, VOL has systematically consolidated its market position to become the world’s largest producer of Isobutyl Benzene (IBB) and 2-Acrylamido-2-Methylpropane Sulfonic Acid (ATBS), commanding an estimated 65% global market share across these flagship product chemistries.
The enterprise functions on an integrated, continuous-flow manufacturing architecture designed to convert basic petrochemical feedstocks into ultra-niche, performance-enhancing organic intermediates and monomers. By manufacturing key inputs internally and maintaining circular atom efficiencies—where industrial by-products are re-engineered into downstream commercial products—the company insulates its operating margin profile from raw material volatility while erecting formidable technological barriers to entry.
- Market Dominance: Commands an undisputed 65% global market share in flagship ATBS and IBB product lines, serving blue-chip industrial conglomerates across five continents.
- Purity & Process Integration: Functions as India’s only integrated producer of Tert-Butyl Amine (TBA), Tert-Butyl Acrylamide (TB Amine / TAB), and Butyl Phenols.
- Global Sustainability Benchmarks: Holds an EcoVadis Gold rating, ranking in the top 5% of global chemical manufacturers for sustainable and ethical operations, supported by a 40 MW captive solar infrastructure that powers 56% of corporate electricity requirements.
The Founders, Promoters & Their Legacy
Vinati Organics was founded by Mr. Vinod Saraf, an industry pioneer whose professional career in the Indian industrial landscape extends across five decades. Prior to establishing VOL in 1989, Mr. Saraf held executive leadership roles at prominent industrial groups including the Bhilwara Group, Modern Syntex (India) Limited, and Grasim Industries, eventually serving as the Managing Director of Mangalore Refinery and Petrochemicals Limited (MRPL). His contributions were acknowledged with the FICCI Lifetime Contribution in Chemicals Award in 2023, the BITS Distinguished Alumnus Award in 2024, and the Rasayan Udyog Ratna Award presented by the Indian Chemical Society.
The operational and strategic leadership of the enterprise transitioned dynamically under Ms. Vinati Saraf Mutreja, who joined the organisation in 2006 and serves as Managing Director & Chief Executive Officer. A dual-degree graduate from the University of Pennsylvania—holding a Bachelor of Science in Economics (Finance) from The Wharton School and a Bachelor of Applied Science from the School of Engineering—she has steered the commercialisation of high-barrier chemistries, export market penetration, and portfolio diversification. Her corporate stewardship has earned her recognition on the World Economic Forum’s Young Global Leaders roster, Forbes Asia’s Power Businesswomen list, and Fortune India’s 100 Most Powerful Women in Business.
Ms. Viral Saraf Mittal, Whole-Time Director designated as Director – CSR, holds a Bachelor of Science in Economics (Finance and Management) from The Wharton School, University of Pennsylvania. Associated with VOL since 2009, she spearheads the corporate social responsibility strategy, social development partnerships, and community welfare programs across industrial hubs in Maharashtra.
The Journey: Corporate History & Key Milestones
The foundational journey of Vinati Organics Limited represents a calculated transition from a single-product Indian chemical manufacturer to a global specialty chemicals supplier across diversified end-markets:
- 1989: Corporate incorporation on June 15, 1989, initiating pilot greenfield operations for Isobutyl Benzene (IBB) in Maharashtra.
- 2002–2006: Commercialisation of 2-Acrylamido-2-Methylpropane Sulfonic Acid (ATBS) using proprietary catalytic process technologies, creating an alternative global sourcing hub for specialty polymer monomers.
- 2010–2018: Systematic capacity debottlenecking across Mahad and Lote complexes, establishing captive Isobutylene (IB) production to achieve total backward integration for ATBS and Butyl Phenols.
- 2020–2024: Commissioning of India’s largest integrated antioxidant manufacturing complex; execution and NCLT approval of the Scheme of Amalgamation of Veeral Additives Private Limited with VOL effective February 2024.
- FY 2024-25 to FY 2025-26: Execution of Phase 1 ATBS capacity expansion from 40,000 MTPA to 50,000 MTPA; operationalisation of wholly owned subsidiary Veeral Organics Private Limited (VOPL) bringing online commercial capacities for MEHQ, Guaiacol, Anisole, 4-MAP, TAA, and PTAP.
The Corporate Umbrella & Group Structure
The corporate umbrella of Vinati Organics Limited encompasses the listed parent operating entity and two wholly owned subsidiaries, complemented by a consolidated controlled structured charitable trust:
- Vinati Organics Limited (Holding Company): The publicly listed operating entity housing core manufacturing facilities at Mahad and Lote for Specialty Aromatics, Specialty Monomers, Butyl Phenols, and Antioxidants.
- Veeral Organics Private Limited (Wholly Owned Subsidiary): Operating entity established in Mahad, Maharashtra, dedicated to downstream specialty chemical derivatives, including MEHQ (Mono Methyl Ether of Hydroquinone), Guaiacol, Anisole, 4-MAP, TAA, and PTAP.
- Vinati Organics USA INC (Wholly Owned Subsidiary): Overseas corporate subsidiary based in the United States, managing North American client distribution, customer service, and technical marketing operations.
- Mrs. Kavita Vinod Saraf Foundation (KVSF): Registered Public Charitable Trust consolidated under Ind AS 110 as a controlled structured entity, through which corporate social responsibility and grassroots development projects are administered.
⚙️ The Business Engine: Segments, Brands, Products & Operations
The Core Divisions & Segment Revenue Breakdown
In accordance with Ind AS 108 (“Operating Segment”), the Company’s operational management reviews the enterprise as a single primary reporting segment: the manufacture and sale of Specialty Chemicals. The geographic and category distribution reflects its diversified application profile across pharmaceuticals, oilfield recovery, water management, agrochemicals, plastics, and personal care.
| Product Category / Division | FY 2025-26 Revenue (₹ Crores) | % Share of Total Product Sales | FY 2024-25 Revenue (₹ Crores) | % Share of Total Product Sales | Latest YoY (%) |
|---|---|---|---|---|---|
| Specialty Chemicals | 2,144.94 | 98.69% | 1,812.55 | 95.90% | +18.34% |
| Others | 28.54 | 1.31% | 77.41 | 4.10% | -63.13% |
| Total Product Revenue | 2,173.48 | 100.00% | 1,889.96 | 100.00% | +15.00% |
Note: Product revenue reflects gross sales minus turnover discounts and variable considerations. Total consolidated revenue from operations stood at ₹2,226.89 Crores in FY 2025-26 (including operating incentives and scrap sales), compared to ₹2,248.17 Crores in FY 2024-25.
The Product & Service Catalog (with Operational KPIs & Order Book)
The manufacturing infrastructure of Vinati Organics supports four primary product verticals, each characterised by specialised synthetic chemistries, proprietary catalyst formulations, and integrated supply loops:
- Specialty Monomers (ATBS & Derivatives): The flagship product line, 2-Acrylamido-2-Methylpropane Sulfonic Acid (ATBS), functions as a performance chemical in enhanced oil recovery (EOR), municipal and industrial water treatment, acrylic fibre processing, personal care, and construction polymers. Phase 1 capacity debottlenecking increased operating capacity from 40,000 MTPA to 50,000 MTPA during the year.
- Specialty Aromatics (IBB & Derivatives): Isobutyl Benzene (IBB) is the primary starting intermediate for the synthesis of Ibuprofen, a foundational non-steroidal anti-inflammatory active pharmaceutical ingredient (API). VOL operates as the low-cost global producer through direct pipeline integration with refineries and integrated petrochemical suppliers.
- Butyl Phenols: A comprehensive product portfolio including Ortho-Tert-Butylphenol (OTBP), Para-Tert-Butylphenol (PTBP), 2,4-Di-Tert-Butylphenol (2,4-DTBP), and 2,6-Di-Tert-Butylphenol (2,6-DTBP). These compounds are deployed in fragrances, agrochemical formulations, resin plasticisers, and lubricant additives, while serving as feedstock for VOL’s downstream antioxidant product line.
- Antioxidants: Stabilising compounds engineered to inhibit oxidative degradation in polymers, plastics, elastomers, and synthetic lubricants. The business vertical achieved a 25% volume expansion during FY 2025-26, transitioning into an independent cash-generating growth vertical.
- Inhibitors & Specialty Intermediates: Specialty compounds including MEHQ, Guaiacol, Anisole, Tert-Butyl Amine, and Tert-Butyl Acrylamide used to arrest spontaneous monomer polymerisation during shipment and storage.
Under Ind AS 108 disclosures, the enterprise maintains an optimal customer diversification profile: no single external customer represents 10% or more of the Company’s total operating revenue during FY 2025-26 or FY 2024-25.
The Names You Know: Key Brands & Flagship Portfolio
| Brand / Product Name | Category / Business Segment | Target Market & Key Positioning |
|---|---|---|
| ATBS (2-Acrylamido-2-Methylpropane Sulfonic Acid) | Specialty Monomers | Enhanced Oil Recovery (EOR), municipal wastewater treatment, acrylic textiles; commands 65% global market share. |
| IBB (Isobutyl Benzene) | Specialty Aromatics | Global pharmaceutical synthesis; primary building block for the Ibuprofen API value chain globally. |
| Butyl Phenol Portfolio (OTBP, PTBP, DTBP) | Aromatic Intermediates | Industrial resins, agrochemicals, fragrance intermediates, and synthetic polymer stabiliser formulations. |
| Antioxidants Suite | Polymer Additives | Safeguarding engineering plastics, elastomers, and industrial lubricants against oxidative thermal breakdown. |
| MEHQ & Guaiacol Chemistries | Polymerisation Inhibitors & Aromatics | Inhibition of monomer auto-polymerisation, bulk pharmaceutical intermediates, and flavour synthesis. |
Mapping the Domestic & Global Reach (India vs. Exports)
Vinati Organics maintains an export-focused operating footprint, marketing specialty intermediates across more than 35 countries worldwide. Exports accounted for 56% of total revenue during FY 2025-26, supported by direct customer integration and global warehouse distribution.
| Geographical Market | FY 2025-26 Revenue (₹ Crores) | % Share of Product Sales | FY 2024-25 Revenue (₹ Crores) | % Share of Product Sales | Latest YoY (%) |
|---|---|---|---|---|---|
| India (Domestic Sourcing) | 1,240.74 | 57.08% | 863.80 | 45.71% | +43.64% |
| Outside India (Exports Across 35+ Nations) | 932.74 | 42.92% | 1,026.13 | 54.29% | -9.10% |
| Total Revenue from External Customers | 2,173.48 | 100.00% | 1,889.93 | 100.00% | +15.00% |
Note: Geographic distribution reflects product sales to external customers. Standalone foreign exchange export earnings under Section 134(3)(m) stood at ₹1,310.59 Crores in FY 2025-26, demonstrating continued global contract execution across the US, Europe, and Asia.
The Brick & Mortar Footprint: Manufacturing Plants, R&D & Offices
The manufacturing capabilities of Vinati Organics are consolidated within four dedicated manufacturing locations across the state of Maharashtra, situated close to primary shipping corridors and seaport export terminals:
- Mahad Works (Site 1 & Site 2): Plot No. B-12 & B-13/1, MIDC Industrial Area, Mahad, District Raigad, Maharashtra – 402 309, and Plot No. K-4/2, Additional MIDC Area, Mahad. Core manufacturing center for IBB, Butyl Phenols, and captive Isobutylene cracking units.
- Veeral Organics Complex (Mahad Site 3): Newly commissioned integrated chemical complex dedicated to downstream niche derivatives including MEHQ, Guaiacol, Anisole, and specialty agrochemical intermediates.
- Lote Works: Plot No. A-20, MIDC Industrial Area, Lote-Parashuram, Taluka Khed, District Ratnagiri, Maharashtra – 415 722. Global-scale continuous-flow manufacturing complex housing ATBS, TB Amine, and Antioxidant production assets.
- Captive Clean Energy Assets: 40 MW operational captive solar power generation capacity (including VOPL facilities), generating 1,39,308 GJ of clean solar energy and supplying 56% of total electricity requirements.
- R&D Infrastructure & Academic Tie-Ups: In-house research and development labs located within manufacturing units, augmented by long-term research partnerships with the Institute of Chemical Technology (ICT), Mumbai, focused on computational fluid dynamics, digital twin reaction modelling, and novel catalytic process synthesis.
📊 The Financial Health: The Numbers Simplified
Multi-Year Financial Highlights (₹ in Crores)
The operational trajectory of Vinati Organics over the five-year period reflects resilient margin defense, disciplined internal accruals, and continuous capital reinvestment across industry cycles:
| Financial Metric | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | Latest YoY (%) |
|---|---|---|---|---|---|---|
| Total Income (₹ Crores) | 2,280.79 | 2,292.39 | 1,939.00 | 2,125.00 | 1,650.00 | -0.51% |
| EBITDA (₹ Crores) | 740.94 | 629.50 | 509.00 | 624.00 | 482.00 | +17.70% |
| Profit After Tax (PAT) (₹ Crores) | 443.74 | 405.25 | 323.00 | 419.00 | 337.00 | +9.50% |
| EBITDA Margin (%) | 32.49% | 27.46% | 26.25% | 29.36% | 29.21% | – |
| PAT Margin (%) | 21.39% | 18.11% | 16.66% | 19.72% | 20.42% | – |
| Net Worth / Total Equity (₹ Crores) | 3,216.61 | 2,806.71 | 2,464.00 | 2,213.00 | 1,862.00 | +14.60% |
| Return on Capital Employed (ROCE) (%) | 18.71% | 18.23% | 17.00% | 24.00% | 22.00% | – |
Note: Multi-year performance highlights are presented based on the historical disclosures reported in the Integrated Annual Report. Detailed Consolidated Ind AS Schedule III financial statements for FY 2025-26 and FY 2024-25 are detailed below.
Earnings, Expenses, & Take-Home Profits (Consolidated Profit & Loss)
During the financial year ended March 31, 2026, consolidated revenue from operations stood at ₹2,226.89 Crores, compared to ₹2,248.17 Crores in the preceding fiscal year. Prudent raw material sourcing and backward integration supported operational profitability: cost of materials consumed dropped 9.80% from ₹1,182.18 Crores to ₹1,066.29 Crores in FY 2025-26. Consolidated Profit Before Tax expanded 10.92% to ₹594.74 Crores (vs. ₹536.18 Crores in FY 2024-25), with consolidated Profit After Tax reaching ₹443.74 Crores, up 9.50% from ₹405.25 Crores in FY 2024-25.
| Consolidated Statement of Profit and Loss Line Items | FY 2025-26 (₹ Crores) | FY 2024-25 (₹ Crores) | Latest YoY (%) |
|---|---|---|---|
| I. Income | |||
| Revenue from Operations | 2,226.89 | 2,248.17 | -0.95% |
| Other Income | 52.64 | 44.31 | +18.80% |
| Total Income | 2,279.53 | 2,292.48 | -0.56% |
| II. Expenses | |||
| Cost of Materials Consumed | 1,066.29 | 1,182.18 | -9.80% |
| Purchase of Stock in Trade | 0.51 | 0.00 | N/M |
| Changes in Inventories of Finished Goods and Work-in-Progress | -32.40 | 13.81 | N/M |
| Employee Benefit Expense | 175.42 | 139.61 | +25.65% |
| Finance Costs | 0.41 | 0.52 | -21.15% |
| Depreciation and Amortisation Expense | 111.36 | 88.53 | +25.79% |
| Other Expenses | 363.20 | 331.65 | +9.51% |
| Total Expenses | 1,684.79 | 1,756.30 | -4.07% |
| Profit Before Tax | 594.74 | 536.18 | +10.92% |
| III. Tax Expense | |||
| Current Tax | 133.56 | 116.61 | +14.54% |
| Deferred Tax | 21.45 | 18.46 | +16.20% |
| Earlier Years Tax Adjustments | -4.01 | -4.14 | -3.14% |
| Total Tax Expense | 151.00 | 130.93 | +15.33% |
| Profit for the Year (PAT) | 443.74 | 405.25 | +9.50% |
| IV. Other Comprehensive Income | |||
| Remeasurements of Defined Benefit Plans | -0.22 | -0.44 | -50.00% |
| Tax Expenses Relating to Items that will not be Reclassified | 0.05 | 0.11 | -54.55% |
| Transfer to Foreign Currency Translation Reserve | -0.03 | 0.00 | N/M |
| Total Other Comprehensive Income for the Year, Net of Tax | -0.20 | -0.33 | -39.39% |
| Total Comprehensive Income for the Year | 443.54 | 404.92 | +9.54% |
| Basic Earnings Per Equity Share (₹) | 42.80 | 39.09 | +9.49% |
| Diluted Earnings Per Equity Share (₹) | 42.80 | 39.09 | +9.49% |
Assets, Borrowings, & Net Worth (Consolidated Balance Sheet)
The consolidated balance sheet of Vinati Organics reflects a conservative financial structure characterised by a debt-free position, substantial tangible capital formation, and a growing net worth. As of March 31, 2026, total equity reached ₹3,161.68 Crores (comprising Equity Share Capital of ₹10.37 Crores and Other Equity of ₹3,151.31 Crores), compared to ₹2,793.28 Crores in the preceding fiscal year. Short-term bank borrowings of ₹62.63 Crores were fully extinguished during the year, resulting in zero debt across both non-current and current lines.
| Consolidated Balance Sheet Line Items | As at March 31, 2026 (₹ Crores) | As at March 31, 2025 (₹ Crores) | Latest YoY (%) |
|---|---|---|---|
| I. Non-Current Assets | |||
| Property, Plant and Equipment | 2,121.63 | 1,723.65 | +23.09% |
| Capital Work-in-Progress (CWIP) | 214.09 | 438.15 | -51.14% |
| Intangible Assets | 0.21 | 0.44 | -52.27% |
| Deferred Tax Assets | 10.49 | 2.17 | +383.41% |
| Non-Current Financial Assets: Investments | 0.00 | 25.89 | -100.00% |
| Non-Current Financial Assets: Other Financial Assets | 1.56 | 2.81 | -44.48% |
| Other Non-Current Assets | 24.99 | 50.38 | -50.40% |
| Total Non-Current Assets | 2,372.97 | 2,243.49 | +5.77% |
| II. Current Assets | |||
| Inventories | 311.13 | 221.20 | +40.66% |
| Current Financial Assets: Investments | 190.45 | 10.00 | +1804.50% |
| Current Financial Assets: Trade Receivables | 521.26 | 592.25 | -11.99% |
| Current Financial Assets: Cash and Cash Equivalents | 3.77 | 0.49 | +669.39% |
| Current Financial Assets: Bank Balances Other than Cash & Cash Equivalents | 2.29 | 3.44 | -33.43% |
| Current Financial Assets: Loans | 0.12 | 0.11 | +9.09% |
| Current Financial Assets: Other Financial Assets | 47.48 | 45.96 | +3.31% |
| Current Tax Assets (Net) | 18.08 | 11.27 | +60.43% |
| Other Current Assets | 121.98 | 153.06 | -20.31% |
| Total Current Assets | 1,216.56 | 1,037.78 | +17.23% |
| TOTAL ASSETS | 3,589.53 | 3,281.27 | +9.39% |
| III. Equity | |||
| Equity Share Capital | 10.37 | 10.37 | 0.00% |
| Other Equity | 3,151.31 | 2,782.91 | +13.24% |
| Total Equity (Net Worth) | 3,161.68 | 2,793.28 | +13.19% |
| IV. Non-Current Liabilities | |||
| Non-Current Borrowings | 0.00 | 0.00 | N/M |
| Other Non-Current Financial Liabilities | 18.05 | 20.65 | -12.59% |
| Deferred Tax Liabilities (Net) | 183.81 | 154.04 | +19.33% |
| Non-Current Provisions | 0.56 | 0.28 | +100.00% |
| Total Non-Current Liabilities | 202.42 | 174.97 | +15.69% |
| V. Current Liabilities | |||
| Current Borrowings | 0.00 | 62.63 | -100.00% |
| Trade Payables: Total Outstanding Dues of MSME | 6.89 | 2.40 | +187.08% |
| Trade Payables: Total Outstanding Dues Other than MSME | 114.38 | 146.05 | -21.68% |
| Other Current Financial Liabilities | 25.75 | 19.66 | +30.98% |
| Other Current Liabilities | 68.30 | 72.86 | -6.26% |
| Current Provisions | 10.08 | 9.42 | +7.01% |
| Current Tax Liabilities (Net) | 0.03 | 0.00 | N/M |
| Total Current Liabilities | 225.43 | 313.02 | -27.98% |
| TOTAL LIABILITIES (Non-Current + Current) | 427.85 | 487.99 | -12.32% |
| TOTAL EQUITY AND LIABILITIES | 3,589.53 | 3,281.27 | +9.39% |
Operational ratios and working capital indicators disclosed under the management discussion and financial disclosures include:
- Liquidity Strength: Current Ratio improved significantly to 5.25x in FY 2025-26 from 3.28x in FY 2024-25, supported by the complete repayment of short-term bank borrowings and healthy treasury liquid mutual fund deployments.
- Solvency & Debt-Equity: Net Debt-Equity ratio stood at 0.00x as of March 31, 2026 (against 0.02x in FY 2024-25), with the Company maintaining a debt-free capital structure.
- Interest Coverage: Interest Coverage Ratio expanded to 1,582.80x in FY 2025-26 from 1,055.29x in FY 2024-25.
- Operating Profit Margin: Operating Profit Margin widened to 28.45% in FY 2025-26 from 23.94% in FY 2024-25, supported by lower input raw material prices.
- Turnover Velocity: Inventory Turnover Ratio moderated to 4.16x in FY 2025-26 (from 4.79x in FY 2024-25) as strategic inventories for the newly commissioned VOPL units were established, while Receivables Turnover Ratio stood stable at 3.96x (compared to 4.00x in FY 2024-25).
Cash Flow: Tracking the Money Movement
Cash flows generated from operations remained healthy throughout the year, driven by operating profitability and working capital realignments. Operating profit before working capital changes stood at ₹683.11 Crores. Following working capital adjustments and net direct taxes paid of ₹136.40 Crores, Net Cash Flow from Operating Activities amounted to ₹557.87 Crores in FY 2025-26 (up 21.75% from ₹458.22 Crores in FY 2024-25). This operational liquidity funded organic capital expenditures of ₹269.57 Crores, total debt liquidation of ₹62.63 Crores, and equity dividend outflows of ₹77.92 Crores.
| Consolidated Statement of Cash Flows Line Items | FY 2025-26 (₹ Crores) | FY 2024-25 (₹ Crores) | Latest YoY (%) |
|---|---|---|---|
| A. Cash Flow from Operating Activities | |||
| Profit Before Tax | 594.74 | 536.18 | +10.92% |
| Depreciation and Amortisation Expense | 111.36 | 88.53 | +25.79% |
| Unrealised Foreign Exchange Gain / Loss | -16.31 | -1.13 | +1343.36% |
| Finance Costs | 0.41 | 0.52 | -21.15% |
| Project Expenses Written Off | 0.00 | 1.52 | -100.00% |
| Interest Income | -0.32 | -14.12 | -97.73% |
| Dividend Income | 0.00 | -0.05 | -100.00% |
| Non Cash Adjustments | 2.65 | 0.00 | N/M |
| Net Gain/Loss on Fair Value Changes on Financial Assets (FVTPL) | -4.25 | -1.74 | +144.25% |
| Net Gain on Sale of Investments Classified at FVTPL | -5.10 | -0.29 | +1658.62% |
| Loss / (Gain) on Sale / Disposal of Property, Plant & Equipment | -0.07 | 1.15 | N/M |
| Operating Profit Before Working Capital Changes | 683.11 | 610.57 | +11.88% |
| Working Capital Adjustments: (Increase) / Decrease in Trade Receivables | 86.35 | -61.12 | N/M |
| Working Capital Adjustments: (Increase) / Decrease in Financial & Other Assets | 27.59 | -13.98 | N/M |
| Working Capital Adjustments: (Increase) / Decrease in Inventories | -89.93 | -22.66 | +296.87% |
| Working Capital Adjustments: Increase / (Decrease) in Trade Payables | -26.25 | 47.27 | N/M |
| Working Capital Adjustments: Increase / (Decrease) in Liabilities & Provisions | 13.40 | -7.44 | N/M |
| Cash Generated from Operations | 694.27 | 552.64 | +25.63% |
| Direct Taxes Paid (Net of Refund) | -136.40 | -94.42 | +44.46% |
| Net Cash Flows from Operating Activities | 557.87 | 458.22 | +21.75% |
| B. Cash Flow from Investing Activities | |||
| Purchase of Property, Plant and Equipment & CWIP (CapEx) | 269.57 | 500.27 | -46.12% |
| Proceeds from Sale of Property, Plant and Equipment | 18.71% | 18.23% | – |
| Purchase of Current Investments | -190.45 | 0.00 | N/M |
| Proceeds from Sale of Current & Non-Current Investments | 18.71% | 18.23% | – |
| Loans / Financial Assets (Given) / Repaid (Net) | -0.01 | 0.02 | N/M |
| Deposits / Balances with Banks Redeemed | 0.78 | 9.56 | -91.84% |
| Interest and Dividend Received | 0.32 | 14.91 | -97.85% |
| Net Cash Flows Used in Investing Activities | -413.50 | -442.51 | -6.56% |
| C. Cash Flow from Financing Activities | |||
| (Repayments) / Proceeds from Working Capital Borrowings (Net) | 18.71% | 18.23% | – |
| Security Deposits (Repaid) / Received | -0.13 | 0.04 | N/M |
| Share Issue Expenses | 0.00 | -0.65 | -100.00% |
| Interest Paid | -0.41 | -0.52 | -21.15% |
| Dividend Paid | -77.92 | -72.43 | +7.58% |
| Net Cash Flows Used in Financing Activities | -141.09 | -15.58 | +805.58% |
| Net Increase / (Decrease) in Cash and Cash Equivalents | 3.28 | 0.12 | +2633.33% |
| Cash and Cash Equivalents at Beginning of the Year | 0.49 | 0.37 | +32.43% |
| Cash and Cash Equivalents at End of the Year | 3.77 | 0.49 | +669.39% |
Funding the Future: CapEx, CWIP, R&D & Foreign Exchange
Vinati Organics maintained steady capital deployment throughout FY 2025-26, funded internally through operating cash flows:
- Capital Expenditure & CWIP: The enterprise invested ₹269.57 Crores in capital assets and project advances during the fiscal year (compared to ₹500.27 Crores in FY 2024-25). CWIP closed at ₹214.09 Crores as of March 31, 2026, down from ₹438.15 Crores in the previous year, as major manufacturing units at Veeral Organics were capitalised into the Property, Plant, and Equipment gross block.
- Capital Commitments: Estimated contracts remaining to be executed on capital account and not provided for stood at ₹66.36 Crores as of March 31, 2026 (compared to ₹187.83 Crores as of March 31, 2025).
- Research & Development Strategy: In-house R&D divisions developed new lubricant additive antioxidants with long-term offtake contracts, while progressing 3 to 4 novel specialty intermediate molecules in the pipeline to support subsequent capex cycles.
- Foreign Exchange Balances (Section 134(3)(m)): Standalone Foreign Exchange Earnings reached ₹1,310.59 Crores in FY 2025-26, compared to a Foreign Exchange Outgo of ₹263.34 Crores, yielding net foreign exchange earnings of ₹1,047.25 Crores.
👥 Power & Control: Corporate Governance, Leadership & Ownership
The Brain Trust: Board of Directors & Key Managerial Personnel (KMP)
The Board of Directors of Vinati Organics Limited comprises an equal representation of Executive and Non-Executive Independent Directors, adhering to statutory governance provisions under the Companies Act, 2013 and SEBI Listing Regulations. The eight-member Board includes 50% Women Directors (4 women directors) and 50% Independent Directors.
| Name of Director / KMP | Designation / Role | DIN | Category |
|---|---|---|---|
| Mr. Vinod Saraf | Executive Chairman | 00076708 | Promoter, Executive Director |
| Ms. Vinati Saraf Mutreja | Managing Director & CEO | 00079184 | Promoter, Executive Director |
| Ms. Viral Saraf Mittal | Director – CSR | 02666028 | Promoter, Executive Director |
| Mr. Amit Harshad Thanawala | Whole-Time Director & COO | 10864545 | Executive Director |
| Mr. Jagdish Chandra Laddha | Independent Director (Audit Committee Chairman) | 00118527 | Non-Executive, Independent Director |
| Ms. Mona Mukund Bhide | Independent Director (Risk Management Committee Chairperson) | 05203026 | Non-Executive, Independent Director |
| Prof. Lakshmi Kantam Mannepalli | Independent Director (NRC & CSR Chairperson) | 07831607 | Non-Executive, Independent Director |
| Dr. Prashant Purushottam Barve | Independent Director | 10455836 | Non-Executive, Independent Director |
| Mr. Gulshan Kumar Sakhuja | Chief Financial Officer (KMP) | – | Key Managerial Personnel (Appointed w.e.f. Nov 06, 2025) |
| Mr. Milind A. Wagh | Company Secretary & Compliance Officer (KMP) | – | Key Managerial Personnel (ICSI FCS: 7125) |
Who Owns the Stock? Shareholding Pattern
The authorised equity share capital of Vinati Organics Limited stands at ₹60.00 Crores divided into 60,00,00,000 equity shares of ₹1/- each. The paid-up, issued, and subscribed share capital as of March 31, 2026, comprises 10,36,65,632 equity shares of face value ₹1/- each, aggregating ₹10.37 Crores.
| Shareholder Category / Name | Number of Shares Held | % of Total Share Capital |
|---|---|---|
| A. Promoter & Promoter Group | ||
| Suchir Chemicals Private Limited | 4,75,53,168 | 45.87% |
| Vinod Saraf Family Trust | 1,38,98,582 | 13.41% |
| Kavita Vinod Saraf Family Trust | 1,24,12,456 | 11.97% |
| Ms. Vinati Saraf Mutreja | 12,10,620 | 1.17% |
| Ms. Viral Saraf Mittal | 10,42,366 | 1.01% |
| Mr. Vinod Saraf | 4,25,136 | 0.41% |
| Viral Alkalis Limited | 4,60,446 | 0.44% |
| Mrs. Kavita Saraf | 2,000 | 0.00% |
| Total Promoter & Promoter Group Stake | 7,70,04,774 | 74.28% |
| B. Institutional Investors | ||
| Domestic Institutional Investors (Mutual Funds & Institutions) | 83,96,916 | 8.10% |
| Foreign Institutional Investors (FIIs / FPIs) | 48,72,285 | 4.70% |
| Insurance Companies | 8,50,058 | 0.82% |
| Total Institutional Holding | 1,41,19,259 | 13.62% |
| C. Public / Non-Institutional Shareholders | ||
| Other Public Shareholders / Retail / NRIs / Bodies Corporate | 1,15,36,011 | 11.13% |
| Investor Education and Protection Fund (IEPF Authority) | 10,05,588 | 0.97% |
| Total Public & Other Shareholding | 1,25,41,599 | 12.10% |
| TOTAL SHARES OUTSTANDING | 10,36,65,632 | 100.00% |
🗺️ The Corporate Family Tree: Group Structure & Strategic Investments
Subsidiaries, Associates, & Joint Ventures (Form AOC-1)
The consolidated performance under Form AOC-1 reflects the financial positions of the two wholly owned subsidiaries and the consolidated controlled public trust for the financial year ended March 31, 2026:
| Entity Name | Relationship | Country | % Equity Held | Turnover (₹ Crores) | Profit / (Loss) After Tax (₹ Crores) | Total Assets (₹ Crores) | Total Liabilities (₹ Crores) |
|---|---|---|---|---|---|---|---|
| Veeral Organics Private Limited (VOPL) | Wholly Owned Subsidiary | India | 100.00% | 21.94 | -39.69 | 723.38 | 23.76 |
| Vinati Organics USA INC | Wholly Owned Subsidiary | United States | 100.00% | 11.05 | 1.48 | 20.84 | 19.38 |
| Mrs. Kavita Vinod Saraf Foundation (KVSF) | Controlled Structured Public Trust (Ind AS 110) | India | 0.00% | 1.13 | 0.82 | 3.48 | 0.00 |
Note: Amounts converted from ₹ Lakhs to ₹ Crores (divided by 100). Veeral Organics Pvt. Ltd. recorded a net loss of ₹39.69 Crores as technical process adjustments were completed ahead of commercial scale-up. Exchange conversion for Vinati Organics USA INC was calculated at ₹94.65 per USD.
Strategic Investments, Credit Facilities & Contingent Liabilities
The company maintains a liquid treasury profile and clear limits on third-party off-balance-sheet commitments:
- Current Treasury Investments: Liquid investments in quoted mutual funds (arbitrage, liquid, and overnight debt instruments) totaled ₹190.45 Crores as of March 31, 2026, compared to ₹10.00 Crores in non-convertible debentures in the prior year.
- Credit Limits & Borrowing Profile: Bank borrowing facilities are rated CARE AA+ (Stable) / CARE A1+ across sanctioned limits of ₹237.00 Crores. Outstanding bank borrowings stood at ₹ Nil as of March 31, 2026, following the complete settlement of short-term credit facilities.
- Contingent Liabilities (Ind AS 37): Contingent liabilities not provided for as of March 31, 2026, include contested electricity duty on co-generation power generation of ₹16.96 Crores, customs duty/IGST obligations against Advance Licenses of ₹11.44 Crores, disputed excise and customs matters of ₹0.47 Crores, and GST disputes of ₹0.20 Crores.
- Capital Commitments & Guarantees: Executable capital account contracts stood at ₹66.36 Crores, supported by outstanding Bank Guarantees of ₹55.61 Crores and Letters of Credit of ₹21.49 Crores.
🎯 The Strategic Outlook: Competitive Moats, Risks & Future Growth Plans
Competitive Advantages & Economic Moats
The durable competitive advantages of Vinati Organics stem from its process integration and process chemistry moat:
- Integrated Chemistry Loop: VOL operates deep backward integration across its product streams. It synthesises captive Isobutylene (IB) internally, transforming basic refinery streams into high-value ATBS, Butyl Phenols, and Antioxidants. This internal sourcing lowers conversion costs and protects operating margins from supply swings.
- Global Scale Leadership: Controlling 65% of global market share in ATBS and IBB establishes economies of scale that discourage new greenfield entrants, creating natural pricing power and customer stickiness with multinational buyers.
- Proprietary Process Innovation: Decades of continuous process re-engineering and in-house catalyst synthesis yield high chemical reaction selectivity, reduced by-product formation, and lower energy usage per metric ton produced.
- Clean Manufacturing Profile: Captive 40 MW solar facilities fulfill 56% of total electricity requirements, and zero-liquid-discharge (ZLD) effluent treatment systems satisfy international ESG standards, enabling the firm to retain an EcoVadis Gold rating (top 5% globally).
What Could Go Wrong? Key Challenges & Business Risks
While the business model demonstrates resilience, specific operational, macroeconomic, and market factors pose potential risks to performance:
- Tariff Actions & Global Trade Shifts: Fluctuating international trade duties, such as US tariffs on Indian chemical exports, can affect price competitiveness and demand patterns across key export geographies.
- VOPL Commercialisation Challenges: Scaling new complex molecules (MEHQ, Guaiacol, 4-MAP, TAA) at Veeral Organics involves process adjustments and engineering adaptations, where delays could postpone margin-accretive contributions from the subsidiary.
- Raw Material Price Swings: Global price swings in basic petrochemical feedstocks can impact short-term inventory valuation and require timely price-pass-through adjustments under long-term client contracts.
- Geographic Concentration in Maharashtra: Primary production assets are concentrated within the Mahad and Lote industrial corridors, exposing operational continuity to regional weather events or utility infrastructure disruptions.
The Next Chapter: Growth, Order Pipeline & CapEx Initiatives
The strategic roadmap for Vinati Organics focuses on defending global market share while scaling newly commercialised downstream product verticals:
- Full Operationalisation of ATBS Expansion: Following the completion of Phase 1 expansion to 50,000 MTPA, the remaining debottlenecking steps are scheduled for completion in FY 2026-27, providing supply capacity to capture demand recovery in oilfield recovery and global wastewater treatment.
- Scaling Antioxidant Chemistries: Transitioning the antioxidant portfolio from initial production into a high-growth volume business, leveraging backward integration into captive butyl phenols to displace higher-cost international suppliers.
- Commercial Rollout of VOPL Derivatives: Ramping up commercial deliveries of MEHQ, Guaiacol, Anisole, 4-MAP, and PTAP at Veeral Organics to support import substitution across the Indian market and diversify export offerings.
- Next-Generation R&D Pipeline: Progressing 3 to 4 proprietary molecules through pilot testing to layout subsequent capex cycles and expand offerings in high-performance polymer additives and pharmaceutical intermediates.
The Verdict: Strategic Outlook & Conclusion
Vinati Organics Limited closed FY 2025-26 with a debt-free balance sheet, ₹3,161.68 Crores in net worth, and a 32.49% standalone operating EBITDA margin. By coupling scale leadership in ATBS and IBB with downstream additions in Antioxidants and VOPL specialty chemicals, the enterprise remains positioned to benefit from supply chain realignments and expanding global demand for integrated specialty chemistry.
Frequently Asked Questions (FAQs) About Vinati Organics
Q1: What are the core chemical products manufactured by Vinati Organics?
Vinati Organics specializes in the manufacture of Specialty Monomers (notably ATBS, where it is the world’s largest producer), Specialty Aromatics (primarily IBB, an essential intermediate for Ibuprofen), Butyl Phenols (OTBP, PTBP, DTBP), Polymer Antioxidants, and specialty inhibitors including MEHQ and Guaiacol.
Q2: What were the latest consolidated revenue and net profit figures reported by the Company?
For the financial year ended March 31, 2026 (FY 2025-26), Vinati Organics reported consolidated Revenue from Operations of ₹2,226.89 Crores, Profit Before Tax of ₹594.74 Crores, and a consolidated Profit After Tax (PAT) of ₹443.74 Crores (up from ₹405.25 Crores in FY 2024-25).
Q3: Who are the key promoters, and what is the shareholding structure?
The enterprise was founded by Executive Chairman Mr. Vinod Saraf and is led by Managing Director & CEO Ms. Vinati Saraf Mutreja. The Promoter and Promoter Group holds 74.28% of the total equity share capital, with Suchir Chemicals Pvt. Ltd. (45.87%), Vinod Saraf Family Trust (13.41%), and Kavita Vinod Saraf Family Trust (11.97%) as the major shareholders.
Q4: Where are the Company’s manufacturing facilities situated, and what is its export footprint?
VOL operates four manufacturing sites across two industrial locations in Maharashtra: Mahad (including the newly commissioned Veeral Organics complex) and Lote-Parashuram. The Company exports to over 35 countries worldwide, with exports contributing 56% of total revenue.
Q5: Does Vinati Organics carry debt, and what is its balance sheet strength?
Vinati Organics maintains a debt-free balance sheet with zero outstanding non-current and current borrowings as of March 31, 2026, following the complete repayment of short-term facilities. Its consolidated net worth stood at ₹3,161.68 Crores with a Current Ratio of 5.25x and bank facility credit ratings of CARE AA+ (Stable) / CARE A1+.
Note: Financial ratios, margins, YoY growth percentages, and % revenue shares are calculated by IndianCompanies.in based on disclosed Ind AS financial statements.
Official Site: https://www.vinatiorganics.com